IR Head - HK Pre IPO Biotech

Shanghai Permanent View Job Description
We are seeking a Head of Investor Relations to lead the company's capital markets strategy and Hong Kong IPO process. Reporting directly to the CEO, this individual will play a critical role in positioning the business for its next phase of growth.
  • Clear HK IPO plan
  • Directly report to CEO

About Our Client

Our client is a PE-backed healthcare company with commercialized products and a strong growth trajectory. Following a significant acquisition and the successful advancement of its financing activities, the company is preparing for a Hong Kong IPO, with an expected filing in early 2027.

Job Description

  • Lead all investor relations activities and serve as the primary interface between the company and the investment community.
  • Develop and articulate a compelling equity story aligned with the company's growth strategy and value proposition.
  • Partner closely with the CEO, CFO, board members, sponsors, and external advisors on IPO preparation and execution.
  • Coordinate key workstreams related to the Hong Kong listing process, including investor messaging, roadshows, analyst engagements, and due diligence activities.
  • Manage relationships with institutional investors, analysts, investment banks, and other capital market participants.
  • Support fundraising initiatives and strategic financing activities prior to IPO.
  • Prepare investor presentations, shareholder communications, management briefing materials, and other capital markets content.
  • Monitor market trends, peer developments, and investor sentiment to provide strategic insights to senior management.
  • Build a investor relations framework to support the company through listing and beyond.



The Successful Applicant

  • Bachelor's degree or above in Finance, Economics, Business, Life Sciences, or a related discipline.
  • Proven Investor Relations experience within the pharmaceutical, biotechnology, medical device, or broader healthcare sector.
  • Strong understanding of Hong Kong capital markets and public market investor communications.
  • Experience engaging with buy-side institutions, sell-side analysts, and capital market stakeholders.
  • Demonstrated ability to work effectively with senior executives and external advisors.
  • Excellent communication, presentation, and stakeholder management skills.
  • Fluent in both Mandarin and English.
  • Prior participation in a full IPO cycle, particularly a Hong Kong listing, will be considered a strong advantage.
  • Experience within a fast-growth, PE-backed, or pre-IPO environment is highly desirable.

What's on Offer

  • Direct exposure to the CEO and board-level decision-making.
  • Opportunity to lead the company's IPO journey from pre-listing preparation through execution.
  • Join a healthcare platform with strong commercial foundations and an expanding pipeline.
  • Play a critical role in important value-creation phases in the company's history.
  • Attractive compensation package, including long-term incentives and significant career development opportunities.
Contact
Stella Mao
Quote job ref
JN-092026-7107674
Phone number
+8621 6026 8063

Job summary

Function
Finance & Accounting
Specialisation
Investor Relations
What is your area of specialisation?
Healthcare / Pharmaceutical
Location
Shanghai
Contract type
Permanent
Consultant name
Stella Mao
Consultant phone
+8621 6026 8063
Job Reference
JN-092026-7107674

Diversity & Inclusion at Michael Page

We don't just accept difference - we celebrate it. We encourage applicants from all backgrounds to apply for this role and are committed to building inclusive, diverse workplaces where everyone can thrive. If you require any support or reasonable adjustments during the recruitment process, please let us know.